ID3通过重组MYC来增强PD-L1表达,以促进结直肠癌的免疫逃避
Chuanzhong Huang1,2,3, Ling Wang1,2, Changhua Zhuo1,2
1Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Medical University, Fuzhou 350014, People's Republic of China.
概括
抑制DNA结合蛋白ID3的抑制剂通过增强PD-L1表达来促进结直肠癌免疫逃避. 向ID3可能会提高免疫治疗对结直肠癌的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 抑制DNA结合蛋白3 (ID3) 的抑制剂与结直肠癌 (CRC) 的进展有关.
- ID3在CRC免疫逃避中的确切作用尚未完全理解.
研究的目的:
- 阐明ID3有助于结直肠癌免疫逃避的机制.
- 调查向ID3以提高免疫疗法疗效的潜力.
主要方法:
- 用RNA测序 (RNA-seq) 来分析基因表达.
- 测试评估PD-L1表达,CD8+T细胞透和激活.
- 染色体免疫沉降测序 (ChIP-seq) 和ImmPort基因组的分析.
- 研究了ID3和MYC转录因子之间的相互作用.
主要成果:
- ID3表达与PD-L1免疫检查点正相关.
- 瘤细胞ID3增强PD-L1表达,抑制CD8+T细胞活性,并促进免疫逃避.
- ID3敲击改善PD-L1阻塞治疗结果,并修改瘤免疫微环境.
- ID3与MYC相互作用,促进PD-L1转录,并影响更广泛的免疫基因调节.
结论:
- ID3通过增强PD-L1表达和MYC相互作用促进结直肠癌的免疫逃避.
- 准ID3是一个有希望的策略,可以改善抗PD-1/PD-L1免疫疗法在CRC.
相关概念视频
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:06Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K